Corrigendum: Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK/NLRP3 inflammasome and IL-6/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study
- PMID: 39268472
- PMCID: PMC11391526
- DOI: 10.3389/fphar.2024.1464358
Corrigendum: Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK/NLRP3 inflammasome and IL-6/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study
Abstract
[This corrects the article DOI: 10.3389/fphar.2024.1381523.].
Keywords: NLRP-3; STAT-3; atorvastatin; major depressive disorder; neuroinflammation.
Copyright © 2024 Aldossary, Saad Ali, Abdallah, Bahaa, Elmasry, Elberri, Kotkata, El Sabaa, Elmorsi, Kamel, Negm, Elberri, Hamouda, AlRasheed, Salahuddin, Yasser and Hamouda.
Erratum for
-
Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK/NLRP3 inflammasome and IL-6/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study.Front Pharmacol. 2024 May 24;15:1381523. doi: 10.3389/fphar.2024.1381523. eCollection 2024. Front Pharmacol. 2024. PMID: 38855751 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous